Egepol Hastaneleri Valuation Multiples

Egepol Hastaneleri is valued at $71M as of September 2026, a 2.4x revenue multiple. In the last fiscal year, Egepol Hastaneleri revenue was $28M and Egepol Hastaneleri EBITDA was $4M.

Egepol Hastaneleri Overview

About Egepol Hastaneleri

Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.


Founded

2009

HQ

Turkey

Employees

N/A

Financials (Last FY)

Revenue: $28M
EBITDA: $4M

EV

$67M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Egepol Hastaneleri Financials

Egepol Hastaneleri reported last fiscal year revenue of $28M and EBITDA of $4M.

In the same fiscal year, Egepol Hastaneleri generated $4M in gross profit, $4M in EBITDA, and $55K in net income.


Egepol Hastaneleri P&L

In the most recent fiscal year, Egepol Hastaneleri reported revenue of $28M and EBITDA of $4M.

Egepol Hastaneleri is profitable as of last fiscal year, with gross margin of 16%, EBITDA margin of 13%, and net margin of 0%.

See analyst estimates for Egepol Hastaneleri
Last FY202620272028
Revenue$28M
Gross Profit$4M
Gross Margin16%
EBITDA$4M
EBITDA Margin13%
EBIT Margin5%
Net Profit$55K
Net Margin0%
Net Debt($2M)

Financial data powered by Morningstar, Inc.

Egepol Hastaneleri Stock Performance

Egepol Hastaneleri has current market cap of $71M, and enterprise value of $67M.


Egepol Hastaneleri's stock price is $0.14.

See more trading valuation data for Egepol Hastaneleri
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$67M$71M-1.9%---$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Egepol Hastaneleri Valuation Multiples

Egepol Hastaneleri trades at 2.4x EV/Revenue multiple, and 18.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Egepol Hastaneleri

Egepol Hastaneleri Financial Valuation Multiples

As of September 24, 2026, Egepol Hastaneleri has market cap of $71M and EV of $67M.

Egepol Hastaneleri has a P/E ratio of 1310.7x.

Last FY202620272028
EV/Revenue2.4x
EV/EBITDA18.9x
EV/EBIT49.7x
EV/Gross Profit15.0x
P/En/m
EV/FCF(79.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Egepol Hastaneleri Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Egepol Hastaneleri Margins & Growth Rates

In the most recent fiscal year, Egepol Hastaneleri reported gross margin of 16%, EBITDA margin of 13%, and net margin of 0%.

See estimated margins and future growth rates for Egepol Hastaneleri

Egepol Hastaneleri Margins

Last FY202720282029
Gross Margin16%
EBITDA Margin13%
EBIT Margin5%
Net Margin0%
FCF Margin(3%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Egepol Hastaneleri Operational KPIs

Access forward-looking KPIs for Egepol Hastaneleri
Last FY202620272028
S&M Expenses to Revenue1%
G&A Expenses to Revenue1%
Opex to Revenue11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Egepol Hastaneleri Competitors

Egepol Hastaneleri competitors include Concord Medical, Giunti Psychometrics, FamiCord, Hyperfine, Lokman Hekim, One Health Group, Medcorp, EuroEyes Eye Clinic, Sudmedica and Clinica de Marly.

Most Egepol Hastaneleri public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Concord Medical$69M($5M)7.7x-(103.4x)-
Giunti Psychometrics$43M$7M1.7x-10.1x-
FamiCord$101M$6M0.7x0.7x11.4x6.0x
Hyperfine$14M($36M)4.0x3.0x(1.5x)(1.7x)
Lokman Hekim$87M$14M1.3x-8.1x-
One Health Group$42M$3M0.9x0.9x11.6x11.6x
Medcorp------
EuroEyes Eye Clinic$101M$29M0.7x-2.5x-

This data is available for Pro users. Sign up to see all Egepol Hastaneleri competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Egepol Hastaneleri

When was Egepol Hastaneleri founded?Egepol Hastaneleri was founded in 2009.
Where is Egepol Hastaneleri headquartered?Egepol Hastaneleri is headquartered in Turkey.
Is Egepol Hastaneleri publicly listed?Yes, Egepol Hastaneleri is a public company listed on Borsa Istanbul.
What is the stock symbol of Egepol Hastaneleri?Egepol Hastaneleri trades under EGEPO ticker.
When did Egepol Hastaneleri go public?Egepol Hastaneleri went public in 2021.
Who are competitors of Egepol Hastaneleri?Egepol Hastaneleri main competitors include Concord Medical, Giunti Psychometrics, FamiCord, Hyperfine, Lokman Hekim, One Health Group, Medcorp, EuroEyes Eye Clinic, Sudmedica, Clinica de Marly.
What is the current market cap of Egepol Hastaneleri?Egepol Hastaneleri's current market cap is $71M.
What is the current revenue of Egepol Hastaneleri?Egepol Hastaneleri's last fiscal year revenue is $28M.
What is the current EV/Revenue multiple of Egepol Hastaneleri?Current revenue multiple of Egepol Hastaneleri is 2.4x.
Is Egepol Hastaneleri profitable?No, Egepol Hastaneleri is not profitable.
How many companies Egepol Hastaneleri has acquired to date?Egepol Hastaneleri hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Egepol Hastaneleri has invested to date?Egepol Hastaneleri hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Egepol Hastaneleri

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial